In this video, senior health-care analyst David Williamson discusses some big news from a pair of Big Pharma companies and one big biotech. Find out what these drug successes and failures mean for these three stocks as well as their competitors.

One nice thing about Big Pharma is that you get paid to wait for drug approvals with nice, juicy dividends. If you're interested in some of these dividends on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called  "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.